New Immune Checkpoint Inhibitor Approved for Bladder Cancer
Learn MoreArtificial Intelligence for the Diagnosis and Treatment of Lymphoma
Learn MoreHonoring National Cancer Survivors Month, Recognizing the AACR Scientist↔Survivor Program®’s Positive Impact
Learn MoreAACR Using Snapchat at Annual Meeting 2017 to Increase Social Engagement
Learn MoreTackling Breast Cancer Health Disparities for Hispanics/Latinas
Learn MoreAACR Journals Editors’ Picks for February
Learn MoreSABCS 2016: The Search for an Effective and Safe PI3K-Inhibitor
Learn MoreDefeating Cancer through Global Education and Training
Learn MoreFDA’s Office of Hematology and Oncology Products Reorganizes
Learn MoreWhat is Convergence? How Can It Further Cancer Research?
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now